Tricida, Inc. (NASDAQ:TCDA) Director Sells $22,700.00 in Stock

Tricida, Inc. (NASDAQ:TCDA) Director Sandra I. Coufal sold 5,000 shares of the business’s stock in a transaction on Monday, April 19th. The shares were sold at an average price of $4.54, for a total transaction of $22,700.00. Following the sale, the director now owns 152,509 shares of the company’s stock, valued at $692,390.86. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Shares of NASDAQ:TCDA traded up $0.12 during midday trading on Wednesday, hitting $4.73. The company had a trading volume of 209,182 shares, compared to its average volume of 685,583. The company has a debt-to-equity ratio of 1.11, a current ratio of 7.00 and a quick ratio of 7.00. The company has a market cap of $237.65 million, a price-to-earnings ratio of -0.88 and a beta of 1.40. Tricida, Inc. has a 12-month low of $3.74 and a 12-month high of $32.99. The company has a fifty day moving average of $5.00 and a two-hundred day moving average of $6.81.

Tricida (NASDAQ:TCDA) last posted its quarterly earnings data on Thursday, February 25th. The company reported ($1.09) EPS for the quarter, missing the consensus estimate of ($1.04) by ($0.05). Research analysts expect that Tricida, Inc. will post -5.24 earnings per share for the current fiscal year.

Several large investors have recently bought and sold shares of TCDA. Citigroup Inc. increased its stake in shares of Tricida by 180.4% in the 4th quarter. Citigroup Inc. now owns 13,441 shares of the company’s stock worth $95,000 after purchasing an additional 8,648 shares in the last quarter. ProShare Advisors LLC increased its stake in Tricida by 21.4% in the 4th quarter. ProShare Advisors LLC now owns 14,008 shares of the company’s stock worth $99,000 after buying an additional 2,473 shares in the last quarter. Jane Street Group LLC purchased a new stake in Tricida in the 4th quarter worth $122,000. The Manufacturers Life Insurance Company increased its stake in Tricida by 10.9% in the 4th quarter. The Manufacturers Life Insurance Company now owns 19,407 shares of the company’s stock worth $137,000 after buying an additional 1,914 shares in the last quarter. Finally, Wells Fargo & Company MN increased its stake in Tricida by 84.2% in the 4th quarter. Wells Fargo & Company MN now owns 23,381 shares of the company’s stock worth $164,000 after buying an additional 10,688 shares in the last quarter. Hedge funds and other institutional investors own 70.46% of the company’s stock.

Separately, Zacks Investment Research upgraded shares of Tricida from a “hold” rating to a “buy” rating and set a $5.25 target price for the company in a research note on Wednesday. One analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the stock. Tricida presently has an average rating of “Hold” and a consensus target price of $16.65.

Tricida Company Profile

Tricida, Inc operates as a pharmaceutical company. It focuses on the development and commercialization of TRC101, a non-absorbed orally-administered polymer that has completed phase 3 trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track.

Read More: What is the Coverage Ratio?

Insider Buying and Selling by Quarter for Tricida (NASDAQ:TCDA)

Receive News & Ratings for Tricida Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tricida and related companies with MarketBeat.com's FREE daily email newsletter.